Distal airway and alveolar model

JP2025523885A5Pending Publication Date: 2026-07-21PHILIP MORRIS PRODUCTS SA
0 Cites 0 Cited by

Patent Information

Application Number
JP2025501889
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-07-15
Filing Date
2023-07-10
Publication Date
2026-07-21

AI Technical Summary

Technical Problem

Current models fail to accurately simulate the interaction between inhalable agents and the distal airways and alveoli, lacking the ability to reproduce physiologically relevant conditions and deposition patterns, and are not designed to hold cell cultures for in vitro exposure.

Method used

A rigid porous foam with an open-cell hierarchical network of macropores and micropores/nanopores is used to simulate the distal airways and alveoli, providing a stable and reproducible model that mimics the anatomical and physiological characteristics of the respiratory tract, including a large, moist surface and optimal flow rates.

Benefits of technology

The model enhances the accuracy and reliability of in vitro methods for inhaled toxicity testing and preclinical evaluation of inhalable agents, allowing for precise simulation of gas exchange and deposition patterns, improving translatability from in vitro to in vivo studies.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

A respiratory simulator including a rigid porous foam is disclosed, the rigid porous foam including (i) macropores, and (ii) an interconnected open cell network of micropores and / or nanopores.
Need to check novelty before this filing date? Find Prior Art